Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $3.07

Daily Change: -$0.0299 / 0.97%

Range: $3.07 - $3.22

Market Cap: $198,486,480

Volume: 6,407

Performance Metrics

1 Week: 26.53%

1 Month: 49.04%

3 Months: 15.24%

6 Months: -52.01%

1 Year: -67.67%

YTD: -19.90%

Company Details

Employees: 65

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

EMX Royalty Corporation (EMX)

Entera Bio Ltd. (ENTX)

Vera Bradley, Inc. (VRA)